Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
NASH Treatment
Sort By
Newest First
Sign in
1 / 1
1 / 1
Proof-of-Concept Trial
Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH
PR-M11-20-014
Nov 18, 2020
Drug Development
New NASH Treatment Achieves Positive Phase III Results
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M02-19-NI-018
Feb 21, 2019
